Equine Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Solution (Equipment & Consumables, Semen, Services), By Equine Type (Sports/Racing, Recreation, Others), By Distribution Channel (Private, Public), By Region and Competition, 2020-2030F
Global Equine Artificial Insemination Market was valued at USD 658.06 million in 2024 and is projected to reach USD 923.24 million by 2030, growing at a compound annual growth rate (CAGR) of 5.78%. This market is experiencing substantial expansion, driven by advancements in reproductive technologies and a growing demand for genetically superior horse breeds. The increasing adoption of artificial insemination (AI) within the equine industry has enabled breeders to enhance genetic diversity and mitigate the risk of disease transmission. The rising popularity of equestrian sports, such as racing, show jumping, and dressage, is further fueling the demand for high-performance horses, thus encouraging the use of assisted reproductive technologies. Industry leaders are focusing on improving semen preservation techniques and innovating insemination methods to enhance fertility rates, resulting in broader adoption of AI across breeding farms and veterinary clinics.
Key Market Drivers:
Genetic Improvement in Equine Traits
The equine breeding industry is undergoing a significant shift, driven by the pursuit of superior genetic traits in horses. This quest for genetic excellence has accelerated the growth of the Global Equine Artificial Insemination (AI) Market as breeders increasingly rely on advanced reproductive technologies to improve and refine the genetic composition of their horses. Artificial insemination offers several advantages over traditional mating methods, including access to genetic material from top sires worldwide, which breaks geographical barriers and diversifies the gene pool. This technology allows breeders to selectively pair stallions with desirable traits—such as speed, endurance, agility, and temperament—to produce offspring suited for various disciplines like racing, show jumping, dressage, and workhorse functions.
Additionally, AI helps preserve genetic diversity within equine populations, minimizing the risks associated with inbreeding by introducing fresh genetic material. The technology also accelerates genetic progress by enabling the production of multiple offspring from a single stallion in one breeding season, thus enhancing the breed's overall quality and performance. The demand for high-quality, genetically superior horses is rising, fueled by competitive sports, leisure riding, and other equine-related activities. As breeders aim to meet these market demands, artificial insemination has become a vital tool in achieving their goals. For instance, the equine industry in the United Kingdom plays a significant role in the economy, with substantial spending on breeding, training, and recreational activities. The Department for Environment, Food & Rural Affairs (DEFRA) regulates equine semen collection and storage, ensuring compliance with rigorous standards to safeguard the health and quality of the equine population.
Key Market Challenges:
Regulatory Compliance: A Complex Landscape
A primary challenge in the equine artificial insemination market is navigating the complex and varied regulatory landscape across different countries and regions. Each jurisdiction has its own set of rules governing equine breeding practices, including the use of artificial insemination. Ensuring compliance with these regulations can be a challenging task, particularly for breeders engaged in international trade. Understanding and adhering to these regulatory requirements is crucial to ensuring the legality and acceptance of artificially inseminated horses in various markets.
Key Market Trends:
Precision Genetic Selection through Genomic Testing
The trend toward precision breeding is gaining traction within the equine industry. Genomic testing, which analyzes an individual horse's DNA to assess its genetic potential, is becoming more accessible and cost-effective. This technology allows breeders to make informed decisions about stallion and mare pairings, optimizing the likelihood of producing offspring with desirable traits. As genomic testing becomes more widely adopted, it is expected to lead to even more selective breeding practices, fostering the creation of superior equine bloodlines.
Key Market Players
In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.
Available Customizations:
Global Equine Artificial Insemination market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers:
Genetic Improvement in Equine Traits
The equine breeding industry is undergoing a significant shift, driven by the pursuit of superior genetic traits in horses. This quest for genetic excellence has accelerated the growth of the Global Equine Artificial Insemination (AI) Market as breeders increasingly rely on advanced reproductive technologies to improve and refine the genetic composition of their horses. Artificial insemination offers several advantages over traditional mating methods, including access to genetic material from top sires worldwide, which breaks geographical barriers and diversifies the gene pool. This technology allows breeders to selectively pair stallions with desirable traits—such as speed, endurance, agility, and temperament—to produce offspring suited for various disciplines like racing, show jumping, dressage, and workhorse functions.
Additionally, AI helps preserve genetic diversity within equine populations, minimizing the risks associated with inbreeding by introducing fresh genetic material. The technology also accelerates genetic progress by enabling the production of multiple offspring from a single stallion in one breeding season, thus enhancing the breed's overall quality and performance. The demand for high-quality, genetically superior horses is rising, fueled by competitive sports, leisure riding, and other equine-related activities. As breeders aim to meet these market demands, artificial insemination has become a vital tool in achieving their goals. For instance, the equine industry in the United Kingdom plays a significant role in the economy, with substantial spending on breeding, training, and recreational activities. The Department for Environment, Food & Rural Affairs (DEFRA) regulates equine semen collection and storage, ensuring compliance with rigorous standards to safeguard the health and quality of the equine population.
Key Market Challenges:
Regulatory Compliance: A Complex Landscape
A primary challenge in the equine artificial insemination market is navigating the complex and varied regulatory landscape across different countries and regions. Each jurisdiction has its own set of rules governing equine breeding practices, including the use of artificial insemination. Ensuring compliance with these regulations can be a challenging task, particularly for breeders engaged in international trade. Understanding and adhering to these regulatory requirements is crucial to ensuring the legality and acceptance of artificially inseminated horses in various markets.
Key Market Trends:
Precision Genetic Selection through Genomic Testing
The trend toward precision breeding is gaining traction within the equine industry. Genomic testing, which analyzes an individual horse's DNA to assess its genetic potential, is becoming more accessible and cost-effective. This technology allows breeders to make informed decisions about stallion and mare pairings, optimizing the likelihood of producing offspring with desirable traits. As genomic testing becomes more widely adopted, it is expected to lead to even more selective breeding practices, fostering the creation of superior equine bloodlines.
Key Market Players
- IMV Technologies SADIR
- Stallion A I Services Ltd
- Zoetis Inc
- Neogen Corp
- Zerlotti Genetics Ltd
- Erc S.r.o.
- CVS UK Ltd
- HOFFMAN A.I. BREEDERS INC.
- Continental Genetics, LLC
- Minitьb GmbH
In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Equine Artificial Insemination Market, By Solution:
- Equipment & Consumables
- Semen
- Normal Semen
- Sexed Semen
- Services
- Equine Artificial Insemination Market, By Equine Type:
- Sports/Racing
- Recreation
- Others
- Equine Artificial Insemination Market, By Distribution Channel:
- Private
- Public
- Equine Artificial Insemination Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.
Available Customizations:
Global Equine Artificial Insemination market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
5.2.3. By Distribution Channel (Private, Public)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Solution
5.3.2. By Equine Type
5.3.3. By Distribution Channel
5.3.4. By Region
6. NORTH AMERICA EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
6.2.2. By Equine Type (Sports/Racing, Recreation, Others)
6.2.3. By Distribution Channel (Private, Public)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Equine Artificial Insemination Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Solution
6.3.1.2.2. By Equine Type
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Equine Artificial Insemination Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Solution
6.3.2.2.2. By Equine Type
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Equine Artificial Insemination Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Solution
6.3.3.2.2. By Equine Type
6.3.3.2.3. By Distribution Channel
7. EUROPE EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
7.2.2. By Equine Type (Sports/Racing, Recreation, Others)
7.2.3. By Distribution Channel (Private, Public)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Equine Artificial Insemination Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Solution
7.3.1.2.2. By Equine Type
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom Equine Artificial Insemination Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Solution
7.3.2.2.2. By Equine Type
7.3.2.2.3. By Distribution Channel
7.3.3. France Equine Artificial Insemination Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Solution
7.3.3.2.2. By Equine Type
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Equine Artificial Insemination Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Solution
7.3.4.2.2. By Equine Type
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Equine Artificial Insemination Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Solution
7.3.5.2.2. By Equine Type
7.3.5.2.3. By Distribution Channel
8. ASIA-PACIFIC EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
8.2.2. By Equine Type (Sports/Racing, Recreation, Others)
8.2.3. By Distribution Channel (Private, Public)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Equine Artificial Insemination Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Solution
8.3.1.2.2. By Equine Type
8.3.1.2.3. By Distribution Channel
8.3.2. Japan Equine Artificial Insemination Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Solution
8.3.2.2.2. By Equine Type
8.3.2.2.3. By Distribution Channel
8.3.3. India Equine Artificial Insemination Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Solution
8.3.3.2.2. By Equine Type
8.3.3.2.3. By Distribution Channel
8.3.4. Australia Equine Artificial Insemination Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Solution
8.3.4.2.2. By Equine Type
8.3.4.2.3. By Distribution Channel
8.3.5. South Korea Equine Artificial Insemination Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Solution
8.3.5.2.2. By Equine Type
8.3.5.2.3. By Distribution Channel
9. SOUTH AMERICA EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
9.2.2. By Equine Type (Sports/Racing, Recreation, Others)
9.2.3. By Distribution Channel (Private, Public)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Equine Artificial Insemination Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Solution
9.3.1.2.2. By Equine Type
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Equine Artificial Insemination Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Solution
9.3.2.2.2. By Equine Type
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Equine Artificial Insemination Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Solution
9.3.3.2.2. By Equine Type
9.3.3.2.3. By Distribution Channel
10. MIDDLE EAST AND AFRICA EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
10.2.2. By Equine Type (Sports/Racing, Recreation, Others)
10.2.3. By Distribution Channel (Private, Public)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Equine Artificial Insemination Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Solution
10.3.1.2.2. By Equine Type
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Equine Artificial Insemination Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Solution
10.3.2.2.2. By Equine Type
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Equine Artificial Insemination Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Solution
10.3.3.2.2. By Equine Type
10.3.3.2.3. By Distribution Channel
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. IMV Technologies SADIR
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Stallion A I Services Ltd
14.3. Zoetis Inc
14.4. Neogen Corp
14.5. Zerlotti Genetics Ltd
14.6. Erc S.r.o.
14.7. CVS UK Ltd
14.8. HOFFMAN A.I. BREEDERS INC.
14.9. Continental Genetics, LLC
14.10. Minitьb GmbH
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
5.2.3. By Distribution Channel (Private, Public)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Solution
5.3.2. By Equine Type
5.3.3. By Distribution Channel
5.3.4. By Region
6. NORTH AMERICA EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
6.2.2. By Equine Type (Sports/Racing, Recreation, Others)
6.2.3. By Distribution Channel (Private, Public)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Equine Artificial Insemination Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Solution
6.3.1.2.2. By Equine Type
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Equine Artificial Insemination Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Solution
6.3.2.2.2. By Equine Type
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Equine Artificial Insemination Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Solution
6.3.3.2.2. By Equine Type
6.3.3.2.3. By Distribution Channel
7. EUROPE EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
7.2.2. By Equine Type (Sports/Racing, Recreation, Others)
7.2.3. By Distribution Channel (Private, Public)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Equine Artificial Insemination Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Solution
7.3.1.2.2. By Equine Type
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom Equine Artificial Insemination Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Solution
7.3.2.2.2. By Equine Type
7.3.2.2.3. By Distribution Channel
7.3.3. France Equine Artificial Insemination Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Solution
7.3.3.2.2. By Equine Type
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Equine Artificial Insemination Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Solution
7.3.4.2.2. By Equine Type
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Equine Artificial Insemination Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Solution
7.3.5.2.2. By Equine Type
7.3.5.2.3. By Distribution Channel
8. ASIA-PACIFIC EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
8.2.2. By Equine Type (Sports/Racing, Recreation, Others)
8.2.3. By Distribution Channel (Private, Public)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Equine Artificial Insemination Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Solution
8.3.1.2.2. By Equine Type
8.3.1.2.3. By Distribution Channel
8.3.2. Japan Equine Artificial Insemination Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Solution
8.3.2.2.2. By Equine Type
8.3.2.2.3. By Distribution Channel
8.3.3. India Equine Artificial Insemination Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Solution
8.3.3.2.2. By Equine Type
8.3.3.2.3. By Distribution Channel
8.3.4. Australia Equine Artificial Insemination Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Solution
8.3.4.2.2. By Equine Type
8.3.4.2.3. By Distribution Channel
8.3.5. South Korea Equine Artificial Insemination Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Solution
8.3.5.2.2. By Equine Type
8.3.5.2.3. By Distribution Channel
9. SOUTH AMERICA EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
9.2.2. By Equine Type (Sports/Racing, Recreation, Others)
9.2.3. By Distribution Channel (Private, Public)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Equine Artificial Insemination Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Solution
9.3.1.2.2. By Equine Type
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Equine Artificial Insemination Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Solution
9.3.2.2.2. By Equine Type
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Equine Artificial Insemination Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Solution
9.3.3.2.2. By Equine Type
9.3.3.2.3. By Distribution Channel
10. MIDDLE EAST AND AFRICA EQUINE ARTIFICIAL INSEMINATION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
10.2.2. By Equine Type (Sports/Racing, Recreation, Others)
10.2.3. By Distribution Channel (Private, Public)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Equine Artificial Insemination Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Solution
10.3.1.2.2. By Equine Type
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Equine Artificial Insemination Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Solution
10.3.2.2.2. By Equine Type
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Equine Artificial Insemination Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Solution
10.3.3.2.2. By Equine Type
10.3.3.2.3. By Distribution Channel
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. IMV Technologies SADIR
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Stallion A I Services Ltd
14.3. Zoetis Inc
14.4. Neogen Corp
14.5. Zerlotti Genetics Ltd
14.6. Erc S.r.o.
14.7. CVS UK Ltd
14.8. HOFFMAN A.I. BREEDERS INC.
14.9. Continental Genetics, LLC
14.10. Minitьb GmbH
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
